Researchers from Merck & Co. said that the drugs they were designed for animals can be an effective treatment for river blindness man debilitating disease that affects hundreds of thousands of poor people in the third world. Development and testing process, however, would be very costly. If the company pays the critical resources to developing drugs, knowing that, even if it was medically successful, it will give a little financial return? Case presents background on economic and scientific constraints that shape the pharmaceutical industry. It serves as a basis for discussion of the ethical aspects of innovative products and the risks and benefits of investing in research and development. It can be used in strategic management, business and society, and ethics courses. "Hide
by Kirk O. Hanson, Stephen Weiss Source: Business Enterprise Trust 5 pages. Publication Date: January 1, 1991. Prod. # Nine ninety-one thousand and twenty-one-PDF-ENG
Related Case Solutions & Analyses:
Greater Minneapolis-St. Paul: Building on a Diversified Base
Baltic Beverages Holding: Competing in a Globalizing World (A)
Identifying Gains and Losses from International Trade: An Exercise
Sloan & Harrison: Non-Equity Partner Discontent
The End of Exponential Growth: Why Real Growth May End Soon
Internationalization Globalization and Capability-Based Strategy
Jardines: Tapping the Asian E-Commerce Market
Asian Financial Crisis: Indonesia and the Currency Board Proposal
Managerial Economics
Micro Economic Analysis
